Drug class
Antiviral-HIV Fixed-Dose Combinations
Antiviral HIV fixed-dose combinations are co-formulated pharmaceutical products that combine two or more antiretroviral medications—often spanning different pharmacological classes, such as reverse transcriptase inhibitors, integrase strand transfer inhibitors, or protease inhibitors—into a single pill or injectable formulation. Read more about Antiviral-HIV Fixed-Dose Combinations
56 drugs in this class 27 manufacturers
Drugs in Antiviral-HIV Fixed-Dose Combinations
EFAVIRENZ-EMTRIC-TENOFOV DISOP (efavirenz/emtricitabine/tenofovir disoproxil fumarate)
EMTRICITABINE-TENOFOVIR DISOP (emtricitabine/tenofovir disoproxil fumarate)
LAMIVUDINE-ZIDOVUDINE (lamivudine/zidovudine)
TRUVADA (emtricitabine/tenofovir disoproxil fumarate)
EMTRICITABINE-TENOFOVIR DISOP (emtricitabine/tenofovir disoproxil fumarate)
LAMIVUDINE-ZIDOVUDINE (lamivudine/zidovudine)
EFAVIRENZ-EMTRIC-TENOFOV DISOP (efavirenz/emtricitabine/tenofovir disoproxil fumarate)
EMTRICITABINE-TENOFOVIR DISOP (emtricitabine/tenofovir disoproxil fumarate)
Antiviral HIV fixed-dose combinations are co-formulated pharmaceutical products that combine two or more antiretroviral medications—often spanning different pharmacological classes, such as reverse transcriptase inhibitors, integrase strand transfer inhibitors, or protease inhibitors—into a single pill or injectable formulation.
These products work by simultaneously targeting distinct stages of the viral replication cycle, suppressing human immunodeficiency virus type 1 (HIV-1) viremia while reducing pill burden and lowering the risk of treatment resistance.
They are primarily utilized in clinical practice for the treatment of HIV-1 infection and, in select formulations, for pre-exposure or post-exposure prophylaxis.
-
fda.gov
Antiviral HIV fixed-dose combinations are co-formulated pharmaceutical products that combine two or more antiretroviral medications—often spanning different pharmacological classes, such as reverse transcriptase inhibitors, integrase strand transfer inhibitors, or protease inhibitors—into a single pill or injectable formulation These products work by simultaneously targeting distinct stages of the viral replication cycle, suppressing human immunodeficiency virus type 1 (HIV-1) viremia while redu...
-
hiv.gov
Antiviral HIV fixed-dose combinations are co-formulated pharmaceutical products that combine two or more antiretroviral medications—often spanning different pharmacological classes, such as reverse transcriptase inhibitors, integrase strand transfer inhibitors, or protease inhibitors—into a single pill or injectable formulation These products work by simultaneously targeting distinct stages of the viral replication cycle, suppressing human immunodeficiency virus type 1 (HIV-1) viremia while redu...
-
hiv.gov
Antiviral HIV fixed-dose combinations are co-formulated pharmaceutical products that combine two or more antiretroviral medications—often spanning different pharmacological classes, such as reverse transcriptase inhibitors, integrase strand transfer inhibitors, or protease inhibitors—into a single pill or injectable formulation These products work by simultaneously targeting distinct stages of the viral replication cycle, suppressing human immunodeficiency virus type 1 (HIV-1) viremia while redu...
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.